These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34403271)

  • 1. An update on the importance of plasma protein binding in drug discovery and development.
    Di L
    Expert Opin Drug Discov; 2021 Dec; 16(12):1453-1465. PubMed ID: 34403271
    [No Abstract]   [Full Text] [Related]  

  • 2. Applying Two Orthogonal Methods to Assess Accuracy of Plasma Protein Binding Measurements for Highly Bound Compounds.
    Ryu S; Riccardi K; Patel R; Zueva L; Burchett W; Di L
    J Pharm Sci; 2019 Nov; 108(11):3745-3749. PubMed ID: 31419399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Industry Perspective on Contemporary Protein-Binding Methodologies: Considerations for Regulatory Drug-Drug Interaction and Related Guidelines on Highly Bound Drugs.
    Di L; Breen C; Chambers R; Eckley ST; Fricke R; Ghosh A; Harradine P; Kalvass JC; Ho S; Lee CA; Marathe P; Perkins EJ; Qian M; Tse S; Yan Z; Zamek-Gliszczynski MJ
    J Pharm Sci; 2017 Dec; 106(12):3442-3452. PubMed ID: 28927987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addressing the Accuracy of Plasma Protein Binding Measurement for Highly Bound Compounds Using the Dilution Method.
    Ryu S; Tess D; Di L
    AAPS J; 2022 Dec; 25(1):7. PubMed ID: 36471200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma Protein Binding of Challenging Compounds.
    Riccardi K; Cawley S; Yates PD; Chang C; Funk C; Niosi M; Lin J; Di L
    J Pharm Sci; 2015 Aug; 104(8):2627-36. PubMed ID: 26037784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein Binding in Translational Antimicrobial Development-Focus on Interspecies Differences.
    Ahmed H; Bergmann F; Zeitlinger M
    Antibiotics (Basel); 2022 Jul; 11(7):. PubMed ID: 35884177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma protein binding: from discovery to development.
    Bohnert T; Gan LS
    J Pharm Sci; 2013 Sep; 102(9):2953-94. PubMed ID: 23798314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving Confidence in the Determination of Free Fraction for Highly Bound Drugs Using Bidirectional Equilibrium Dialysis.
    Chen YC; Kenny JR; Wright M; Hop CECA; Yan Z
    J Pharm Sci; 2019 Mar; 108(3):1296-1302. PubMed ID: 30326208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro, in silico and integrated strategies for the estimation of plasma protein binding. A review.
    Lambrinidis G; Vallianatou T; Tsantili-Kakoulidou A
    Adv Drug Deliv Rev; 2015 Jun; 86():27-45. PubMed ID: 25819487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid equilibrium dialysis, ultrafiltration or ultracentrifugation? Evaluation of methods to quantify the unbound fraction of substances in plasma.
    Dimitrijevic D; Fabian E; Funk-Weyer D; Landsiedel R
    Biochem Biophys Res Commun; 2023 Apr; 651():114-120. PubMed ID: 36812744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein binding in antiretroviral therapies.
    Boffito M; Back DJ; Blaschke TF; Rowland M; Bertz RJ; Gerber JG; Miller V
    AIDS Res Hum Retroviruses; 2003 Sep; 19(9):825-35. PubMed ID: 14585213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facing the Facts of Altered Plasma Protein Binding: Do Current Models Correctly Predict Changes in Fraction Unbound in Special Populations?
    Al-Qassabi J; Tan SPF; Phonboon P; Galetin A; Rostami-Hodjegan A; Scotcher D
    J Pharm Sci; 2024 Jun; 113(6):1664-1673. PubMed ID: 38417790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct determination of the ratio of unbound fraction in plasma to unbound fraction in microsomal system (fu p/fu mic) for refined prediction of phase I mediated metabolic hepatic clearance.
    Deshmukh SV; Harsch A
    J Pharmacol Toxicol Methods; 2011; 63(1):35-9. PubMed ID: 20433934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of plasma protein and tissue binding in a drug discovery program to successfully deliver a preclinical candidate.
    Hann E; Malagu K; Stott A; Vater H
    Prog Med Chem; 2022; 61():163-214. PubMed ID: 35753715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Method for Preventing Non-specific Binding in Equilibrium Dialysis Assays Using Solutol® as an Additive.
    Srivastava A; Pike A; Williamson B; Fenner K
    J Pharm Sci; 2021 Mar; 110(3):1412-1417. PubMed ID: 33248055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using Counter Equilibrium Dialysis (CED) to Increase Confidence in the Measurement of Free Fraction for Challenging Compounds.
    Huang J; Yan Z; Cai J
    J Pharm Sci; 2023 Sep; 112(9):2561-2569. PubMed ID: 37187260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein-binding characteristics of voriconazole determined by high-throughput equilibrium dialysis.
    Vanstraelen K; Wauters J; De Loor H; Vercammen I; Annaert P; Lagrou K; Spriet I
    J Pharm Sci; 2014 Aug; 103(8):2565-70. PubMed ID: 24961809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma protein binding in drug discovery and development.
    Howard ML; Hill JJ; Galluppi GR; McLean MA
    Comb Chem High Throughput Screen; 2010 Feb; 13(2):170-87. PubMed ID: 20053162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery.
    Smith DA; Di L; Kerns EH
    Nat Rev Drug Discov; 2010 Dec; 9(12):929-39. PubMed ID: 21119731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategy for Determining the Free Fraction of Labile Covalent Modulators in Plasma Using Equilibrium Dialysis.
    Leung C; Kenny JR; Hop CECA; Yan Z
    J Pharm Sci; 2020 Oct; 109(10):3181-3189. PubMed ID: 32663597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.